Effect of Daily Consumption of <i> Lactobacillus reuteri </i> CRL 1098 on Cholesterol Reduction in Hypercholesterolemic Subjects — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Effect of Daily Consumption of <i> Lactobacillus reuteri </i> CRL 1098 on Cholesterol Reduction in Hypercholesterolemic Subjects
IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
,
CERELA—Centro de Referencia para Lactobacilos (CONICET), Tucumán, Argentina
,
Sancor CUL, Departamento de Investigación, Innovación y Desarrollo, Sunchales, Argentina
,
IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
,
IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
,
Sancor CUL, Departamento de Investigación, Innovación y Desarrollo, Sunchales, Argentina
,
IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
,
Sancor CUL, Departamento de Investigación, Innovación y Desarrollo, Sunchales, Argentina
,
CERELA—Centro de Referencia para Lactobacilos (CONICET), Tucumán, Argentina
,
CERELA—Centro de Referencia para Lactobacilos (CONICET), Tucumán, Argentina
,
IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
,
IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
,
IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
1 IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
2 CERELA—Centro de Referencia para Lactobacilos (CONICET), Tucumán, Argentina
3 Sancor CUL, Departamento de Investigación, Innovación y Desarrollo, Sunchales, Argentina
4 IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
5 IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
6 Sancor CUL, Departamento de Investigación, Innovación y Desarrollo, Sunchales, Argentina
7 IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
8 Sancor CUL, Departamento de Investigación, Innovación y Desarrollo, Sunchales, Argentina
9 CERELA—Centro de Referencia para Lactobacilos (CONICET), Tucumán, Argentina
10 CERELA—Centro de Referencia para Lactobacilos (CONICET), Tucumán, Argentina
11 IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
12 IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
13 IDIP—Instituto de Desarrollo e Investigaciones Pediátricas “Prof. Dr. Fernando E. Viteri” (Hospital de Niños de La Plata, Ministerio de Salud/Comisión de Investigaciones Científicas de la Pro-vincia de Buenos Aires), La Plata, Argentina
The effect of daily consumption of a yogurt containing Lactobacillus reuteri CRL 1098 on the lipid profile of hypercholesterolemic subjects was evaluated by performing a prospective, randomized, double-blind, cross-over placebo controlled clinical study. Participants consumed daily a yogurt containing L. reuteri CRL 1098 or a placebo for four weeks, separated by a wash-out period. Total cholesterol, triacylglycerol, high-density (HDL) and low-density (LDL) lipoprotein levels were assessed at the beginning and at the end of each period. We found a statistically significant reduction of total ( – 7.86 g/dl) and LDL ( – 7.02 g/dl) cholesterol in absolute changes (before-after) as well as a decreasing trend in the group receiving the yogurt containing L. reuteri with respect to the placebo group, without detecting changes in HDL-cholesterol and triacylglycerol levels. Our results suggest that low amounts of yogurt (125 g/day) and low doses of the CRL 1098 strain (10 6 CFU) are sufficient to reduce total and LDL-cholesterol levels in hypercholesterolemic subjects.
Puska, P., Tuomilehto, J., Nissinen, A., Salonen, J.T., Vartiainen, E., Pietinen, P., Koskela, K. and Korhonen, H.J. (1989) The North Karelia Project: 15 Years of Community-Based Prevention of Coronary Heart Disease. Annals of Medicine, 21, 169-173. http://dx.doi.org/10.3109/07853898909149928
Roy, S. (2014) Atherosclerotic Cardiovascular Disease Risk and Evidence-Based Management of Cholesterol. North American Journal of Medical Science, 6, 191-198. http://dx.doi.org/10.4103/1947-2714.132916
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III). Journal of the American Medical Association, 285, 2486-2497. http://dx.doi.org/10.1001/jama.285.19.2486
World Health Organization (2014) Global Status Report on Noncommunicable Diseases 2014. http://www.who.int/nmh/publications/ncd-status-report-2014/en/
Chen, G., Wang H., Zhang, X. and Tian, Yang S. (2014) Nutraceuticals and Functional Foods in the Management of Hyperlipidemia. Critical Reviews in Food Science and Nutrition, 54, 1180-1201. http://dx.doi.org/10.1080/10408398.2011.629354
Jones, M.L., Tomaro-Duchesneau, C., Martoni, C.J. and Prakash, S. (2013) Cholesterol Lowering with Bile Salt Hydrolase-Active Probiotic Bacteria, Mechanism of Action, Clinical Evidence, and Future Direction for Heart Health Applications. Expert Opinion on Biological Therapy, 13, 631-642. http://dx.doi.org/10.1517/14712598.2013.758706
Kumar, M., Nagpal, R., Kumar, R., Hemalatha, R., Verma, V., Kumar, A., Chakraborty, C.H., Singh, B., Marotta, F., Jain, S. and Yadav, H. (2012) Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases. Experimental Diabetes Research, 2012, 2-16. http://dx.doi.org/10.1155/2012/902917
Ooi, L.-G. and Liong, M.-T. (2010) Cholesterol-Lowering Effects of Probiotics and Prebiotics: A Review of in Vivo and in Vitro Findings. International Journal of Molecular Science, 11, 2499-2522. http://dx.doi.org/10.3390/ijms11062499
Pereira, D.I.A. and Gibson, G.R. (2002) Effects of Consumption of Probiotics and Prebiotics on Serum Lipid Levels in Humans. Critical Reviews Biochemistry Molecular Biology, 37, 259-281. http://dx.doi.org/10.1080/10409230290771519
Ataie-Jafari, A., Larijani, B. and Majd, H.A. (2009) Cholesterol-Lowering Effect of Probiotic Yogurt in Comparison with Ordinary Yogurt in Mildly to Moderately Hypercholesterolemic Subjects. Annals Nutrition and Metabolism, 54, 22-27. http://dx.doi.org/10.1159/000203284
Xiao, J.Z., Kondo, S., Takahashi, N., Miyaji, K., Oshida, K., Hiramatsu, A., Iwatsuki, K., Kokubo, S. and Hosono, A. (2003) Effects of Milk Products Fermented by Bifidobacterium longum on Blood Lipids in Rats and Healthy Adult Male Volunteers. Journal of Dairy Science, 86, 2452-2461. http://dx.doi.org/10.3168/jds.S0022-0302(03)73839-9
Anderson, J.W. and Gilliland, S.E. (1999) Effect of Fermented Milk (Yogurt) Containing Lactobacillus acidophilus L1 on Serum Cholesterol in Hypercholesterolemic Humans. Journal of the American College of Nutrition, 18, 43-50. http://dx.doi.org/10.1080/07315724.1999.10718826
De Roos, N.M., Schouten, G. and Katan, M.B. (1999) Yogurt Enriched with Lactobacillus acidophilus Does Not Lower Blood Lipids in Healthy Men and Women with Normal to Borderline High Serum Cholesterol Levels. European Journal of Clinical Nutrition, 53, 277-280. http://dx.doi.org/10.1038/sj.ejcn.1600722
Lewis, S.J. and Burmeister, S. (2005) A Double-Blind Placebo-Controlled Study of the Effects of Lactobacillus acidophilus on Plasma Lipids. European Journal of Clinical Nutrition, 59, 776-780. http://dx.doi.org/10.1038/sj.ejcn.1602139
Simons, L.A., Armansec, S.G. and Conway, P. (2006) Effect of Lactobacillus fermentum on Serum Lipids in Subjects with Elevated Serum. Nutrition, Metabolism and Cardiovascular Disease, 16, 531-535. http://dx.doi.org/10.1016/j.numecd.2005.10.009
Taranto, M.P., Medici, M., Perdigon, G., Ruiz Holgado, A.P. and Valdez, G.F. (2000) Effect of Lactobacillus reuteri on the Prevention of Hypercholesterolemia in Mice. Journal of Dairy Science, 83, 401-403. http://dx.doi.org/10.3168/jds.S0022-0302(00)74895-8
Taranto, M.P., Medici, M., Perdigon, G., Ruiz Holgado, A.P. and Valdez, G.F. (1998) Evidence for Hypocholesterolemic Effect of Lactobacillus reuteri in Hypercholesterolemic Mice. Journal of Dairy Science, 81, 2336-2340. http://dx.doi.org/10.3168/jds.S0022-0302(98)70123-7
International Physical Activity Questionnaire (IPAQ). (2010) https://docs.google.com/viewer?a=v&pid=sites&srcid=ZGVmYXVsdGRvbWFpbnx0aGVpcGFxfGd4OjJhOTZhOGFhMWNjNzI0NTI
Salas-Salvadó, J., Fernandez-Ballart, J., Ros, E., Martinez-Gonzalez, N.A. et al., PREDIMED Study Investigators. (2008) Effect of the Mediterranean Diet Supplemented with Nuts on Metabolic Syndrome Status. Archives of Internal Medicine, 168, 2449-2458. http://dx.doi.org/10.1001/archinte.168.22.2449
World Health Organization (2001) STEPwise Approach to Surveillance (STEPS). http://www.who.int/chp/steps/Instrumento_STEPS_v2.1_ES.pdf
Agerbaek, M., Gerdes, L.U. and Richelsen, B. (1995) Hypocholesterolaemic Effect of a New Fermented Milk Product in Healthy Middle-Aged Men. European Journal of Clinical Nutrition, 49, 346-352.
Agerholm-Larsen, L., Raben, A., Haulrik, N., Hansen, A.S., Manders, M. and Astrup, A. (2000) Effect of 8 Week Intake of Probiotic Milk Products on Risk Factors for Cardiovascular Diseases. European Journal of Clinical Nutrition, 54, 288-297. http://dx.doi.org/10.1038/sj.ejcn.1600937
Bertolami, M.C., Faludi, A.A. and Batlouni, M. (1999) Evaluation of the Effects of a New Fermented Milk Product (Gaio) on Primary Hypercholesterolemia. European Journal of Clinical Nutrition, 53, 97-101. http://dx.doi.org/10.1038/sj.ejcn.1600683
Sessions, V.A., Lovegrove, J.A., Dean, T.S., Williams, C.M., Sanders, T.A.B., Macdonald, I.A. and Salter, A.M. (1998) The Effect of a New Fermented Milk Product on Plasma Cholesterol and Apolipoprotein B Concentrations in Middle- Aged Men and Women. In: Sadler, M.J. and Saltmarch, M., Eds., Functional Foods—The Consumer, the Products and the Evidence, Royal Society of Chemistry, London, 15-19.
Schaafsma, G., Meuling, W.J., Van Dokkum, W. and Bouley, C. (1998) Effects of a Milk Product, Fermented by Lactobacillus acidophilus and with Fructo-Oligosaccharides Added, on Blood Lipids in Male Volunteers. European Journal of Clinical Nutrition, 52, 436-440. http://dx.doi.org/10.1038/sj.ejcn.1600583
Lin, S.Y., Ayres, J.W., Winkler Jr., W. and Sandine, W.E. (1989) Lactobacillus Effects on Cholesterol: In Vitro and in Vivo Results. Journal of Dairy Science, 72, 2885-2899. http://dx.doi.org/10.3168/jds.S0022-0302(89)79439-X
Sadrzadeh-Yeganeh, H., Elmadfa, I., Djazayery, A., Jalali, M., Heshmat, R. and Chamary, M. (2010) The Effects of Probiotic and Conventional Yoghurt on Lipid Profile in Women. British Journal of Nutrition, 103, 1778-1783. http://dx.doi.org/10.1017/S0007114509993801
Jones, M.L., Martoni, C.J., Parent, M. and Prakash, S. (2012) Cholesterol-Lowering Efficacy of a Microencapsulated Bile Salt Hydrolase-Active Lactobacillus reuteri NCIMB 30242 Yoghurt Formulation in Hypercholesterolaemic Adults. British Journal of Nutrition, 107, 1505-1513. http://dx.doi.org/10.1017/S0007114511004703
Jones, M.L., Martoni, C.J. and Prakash, S. (2012) Cholesterol Lowering and Inhibition of Sterol Absorption by Lactobacillus reuteri NCIMB 30242: A Randomized Controlled Trial. European Journal of Clinical Nutrition, 66, 1234- 1241. http://dx.doi.org/10.1038/ejcn.2012.126
Guo, Z., Liu, X.M., Zhang, Q.X., Shen, Z., Tian, F.W., Zhang, H., Sun, Z.H., Zhang, H.P. and Chen, W. (2011) Influence of Consumption of Probiotics on the Plasma Lipid Profile: A Meta-Analysis of Randomized Controlled Trials. Nutrition, Metabolism and Cardiovascular Disease, 21, 844-850. http://dx.doi.org/10.1016/j.numecd.2011.04.008
Manson, J.E., Tosteson, H., Satterfield, S., Hebert, P., O’Connor, G.T., Buring, J.E. and Hennekens, C.H. (1992) The Primary Prevention of Myocardial Infarction. New England Journal of Medicine, 326, 1406-1416. http://dx.doi.org/10.1056/NEJM199205213262107